search
Back to results

Effects of the DASH vs. the Mediterranean Diet Combined With Salt Restriction on Blood Pressure Levels in Adults

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Salt Restriction Group (SRG)
DASH Diet combined with salt restriction Group (DDG)
Mediterranean Diet combined with salt restriction Group (MDG)
Sponsored by
Hippocration General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension focused on measuring Hypertension, Blood pressure, Diet, Salt, Dietary Approaches to Stop Hypertension, Mediterranean, Dietary pattern

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: High normal BP (office systolic BP: 130-139 mmHg and/or office diastolic BP: 85-89 mmHg) or grade 1 hypertension (office systolic BP: 140-159 mmHg and/or office diastolic BP: 90-99 mmHg) and low-moderate 10-year cardiovascular disease risk. Willingness to participate in a dietary intervention to control BP and to attend individual sessions. Signed informed consent form for participation. Exclusion Criteria: Current use of anti-hypertensive medications. Current use of any other medications or agents affecting BP levels (e.g., nonsteroidal anti-inflammatory drugs). Use of food supplements accompanied by a refusal to discontinue them. Participation in a clinical study involving a drug or device within 3 months of screening. Active weight loss or participation in a weight loss treatment program within 3 months of screening. Secondary hypertension. Atomic history of cardiovascular disease (e.g. acute myocardial infarction, stroke, heart failure). Diabetes Mellitus (Type 1 & 2). Chronic kidney disease, defined as an estimated Glomerular Filtration Rate (eGFR) <60 mL/min/1.73m2. Liver disease (e.g., hepatitis, cirrhosis). Lung disease (e.g., chronic obstructive pulmonary disease). Inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis). Celiac disease. Active malignancy or cancer therapy. Current major psychiatric disorder or current drug abuse. Body Mass Index >40 kg/m2. Current alcohol consumption >14 drinks per week. Current or planned pregnancy before the end of the study, or breast-feeding. Any concomitant conditions that in the opinion of the investigator interfere with the diet or other situations requiring specific nutritional management.

Sites / Locations

  • Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, National and Kapodistrian University of Athens

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Control Group (CG)

Salt Restriction Group (SRG)

DASH Diet combined with salt restriction Group (DDG)

Mediterranean Diet combined with salt restriction Group (MDG)

Arm Description

Patients continued to consume their usual diet for 3 months

Patients continued to consume their usual diet, but they restricted sodium intake to 2,000 mg/ day for 3 months.

Patients consumed the DASH diet for 3 months.

Patients consumed the MedDiet diet for 3 months.

Outcomes

Primary Outcome Measures

Office systolic blood pressure (BP)
The attained mean office systolic BP difference among the randomized arms

Secondary Outcome Measures

Office diastolic blood pressure (BP)
The attained mean office diastolic BP difference among the randomized arms
Ambulatory systolic and diastolic blood pressure (BP)
The attained between-group differences regarding the mean ambulatory BP measurements (during 24h, daytime, and night-time)
Odds of hypertension
The odds of hypertension according to the office BP measurements in each study group
Metabolic syndrome and its components
The attained between-group differences in metabolic syndrome presence and in the presence of individual metabolic syndrome components

Full Information

First Posted
December 14, 2022
Last Updated
September 8, 2023
Sponsor
Hippocration General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05669404
Brief Title
Effects of the DASH vs. the Mediterranean Diet Combined With Salt Restriction on Blood Pressure Levels in Adults
Official Title
Effects of the DASH and the Mediterranean Diet Combined With Salt Restriction on Blood Pressure Levels and Cardiometabolic Risk Factors in Adults With High Normal Blood Pressure or Grade 1 Hypertension: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
January 7, 2019 (Actual)
Primary Completion Date
May 27, 2022 (Actual)
Study Completion Date
September 9, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hippocration General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Non-pharmacological measures should serve as the first-line treatment in individuals with high normal blood pressure (BP) levels or grade 1 hypertension and low-moderate cardiovascular disease risk. Salt intake reduction and the dietary patterns of the Dietary Approaches to Stop Hypertension (DASH) diet and the Mediterranean diet (MedDiet) have been recognized as effective dietary measures for BP reduction. To the best of our knowledge, no clinical trials were designed to compare the effects of these dietary strategies. The purpose of the present trial was to compare the effects of salt restriction, the DASH, and the MedDiet combined with the salt restriction on BP levels and cardiometabolic risk factors in adults with high normal BP or grade 1 hypertension over 3 months.
Detailed Description
This was a 3-month, single-center, single-blind, randomized, controlled, clinical trial, with 4 parallel groups. Before their randomization, the potential participants visiting the Hypertension Unit of the Hippocration General Hospital of Athens for the first time were assessed for eligibility during two screen visits. Anthropometric measurements, demographic characteristics, dietary intake, physical activity level, smoking history, and alcohol consumption were recorded. In addition, office and ambulatory BP measurements, as well as fasting blood samples and 24-hour urine samples were obtained. Patients were eligible for inclusion if they had high normal BP (office systolic BP: 130-139 mmHg and/or office diastolic BP: 85-89 mmHg) or grade 1 hypertension (office systolic BP: 140-159 mmHg and/or office diastolic BP: 90-99 mmHg), based on the average of the means of the last two out of three measurements made during the two screen visits and were free of antihypertensive drug treatment and major medical conditions. Enrolled patients were blindly randomized to one of the four study groups, i.e., control group (CG), salt restriction group (SRG), DASH diet combined with salt restriction group (DDG), or MedDiet combined with salt restriction group (MDG). After randomization, all patients were followed monthly for 3 months in individual sessions, coordinated by the clinical dietician. For the patients of all four study groups, the goal was to maintain the initial body weight stable. Patients in the CG received the usual advice about salt restriction given to the patients by the clinical dietician at the Hypertension Unit. They were followed at the same frequency as the patients in the other study groups to obtain the study's intended measurements, without any other intervention. For the patients in the three intervention groups, the goal was to limit sodium intake to 2,000 mg/ day. Patients in the SRG were given a detailed booklet containing information about table salt and during each 45-min individual session, they received intensive counselling and training to increase adherence to salt restriction. Patients in the DDG and the MDG received a more extensive booklet, which also contained information about the assigned dietary pattern and an individualized eating plan, while during the 45-min individual sessions, patients in these two intervention groups were intensively counselled and trained to increase adherence to salt restriction and the assigned dietary pattern. Adherence to the assigned diet and/or salt restriction was established through subjective and objective measures, i.e., 7-day food records, adherence scores, and 24-hour urine tests. Anthropometric indices, dietary intake, physical activity level, and office BP were measured at baseline, and during each follow-up visit. Ambulatory BP measurements and collection of fasting blood samples and 24-hour urine samples were conducted at baseline and the end of the 3-month intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, Blood pressure, Diet, Salt, Dietary Approaches to Stop Hypertension, Mediterranean, Dietary pattern

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Enrolled patients were blindly randomized with a 1:1:1:1 allocation to one of the four study groups, i.e., control group (CG), salt restriction group (SRG), DASH diet combined with salt restriction group (DDG), or MedDiet combined with salt restriction group (MDG).
Masking
Care ProviderInvestigatorOutcomes Assessor
Masking Description
Due to the nature of this study, which was a dietary intervention evaluating the effect of certain dietary strategies on blood pressure levels and cardiometabolic risk factors, masking of the trial participants and the clinical dietician (sub-investigator), who provided the dietary education and was solely responsible for the assignment of patients to the study groups was not possible. However, patients were completely unaware of the other groups of the study and were treated according to strict criteria, preventing deviations from the intended intervention. Moreover, the principal investigator, care providers, and all members of the medical team, who conducted the office and the ambulatory BP measurements (outcomes assessors) were blinded to patients' allocations.
Allocation
Randomized
Enrollment
240 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control Group (CG)
Arm Type
No Intervention
Arm Description
Patients continued to consume their usual diet for 3 months
Arm Title
Salt Restriction Group (SRG)
Arm Type
Experimental
Arm Description
Patients continued to consume their usual diet, but they restricted sodium intake to 2,000 mg/ day for 3 months.
Arm Title
DASH Diet combined with salt restriction Group (DDG)
Arm Type
Experimental
Arm Description
Patients consumed the DASH diet for 3 months.
Arm Title
Mediterranean Diet combined with salt restriction Group (MDG)
Arm Type
Experimental
Arm Description
Patients consumed the MedDiet diet for 3 months.
Intervention Type
Behavioral
Intervention Name(s)
Salt Restriction Group (SRG)
Intervention Description
Patients assigned to the SRG continued to consume their usual diet, but they had to restrict their sodium intake to 2,000 mg/ day. They were given a detailed booklet containing information about table salt, foods rich in sodium, and practical ways to decrease salt consumption. During each 45-min individual session, they received intensive counselling and training to increase adherence to salt restriction. Also, they were instructed to keep their body weight stable and not to change their physical activity level over the next 3 months.
Intervention Type
Behavioral
Intervention Name(s)
DASH Diet combined with salt restriction Group (DDG)
Intervention Description
Patients assigned to the DDG received a more extensive booklet, which which in addition to the information regarding salt restriction, contained detailed information about the DASH diet, and practical advice about how to start and stay on the assigned dietary pattern. In addition to the booklet, each patient received an individualized eating plan with six sample daily menus, incorporating the goals of the DASH diet. During the 45-min individual sessions, patients were intensively counselled and trained to increase adherence to salt restriction and the assigned dietary pattern. Also, they were instructed to keep their body weight stable and not to change their physical activity level over the next 3 months.
Intervention Type
Behavioral
Intervention Name(s)
Mediterranean Diet combined with salt restriction Group (MDG)
Intervention Description
Patients assigned to the MDG received a more extensive booklet, which which in addition to the information regarding salt restriction, contained detailed information about the MedDiet, and practical advice about how to start and stay on the assigned dietary pattern. In addition to the booklet, each patient received an individualized eating plan with six sample daily menus, incorporating the goals of the MedDiet diet. During the 45-min individual sessions, patients were intensively counselled and trained to increase adherence to salt restriction and the assigned dietary pattern. Also, they were instructed to keep their body weight stable and not to change their physical activity level over the next 3 months.
Primary Outcome Measure Information:
Title
Office systolic blood pressure (BP)
Description
The attained mean office systolic BP difference among the randomized arms
Time Frame
3 months post-intervention
Secondary Outcome Measure Information:
Title
Office diastolic blood pressure (BP)
Description
The attained mean office diastolic BP difference among the randomized arms
Time Frame
3 months post-intervention
Title
Ambulatory systolic and diastolic blood pressure (BP)
Description
The attained between-group differences regarding the mean ambulatory BP measurements (during 24h, daytime, and night-time)
Time Frame
3 months post-intervention
Title
Odds of hypertension
Description
The odds of hypertension according to the office BP measurements in each study group
Time Frame
3 months post-intervention
Title
Metabolic syndrome and its components
Description
The attained between-group differences in metabolic syndrome presence and in the presence of individual metabolic syndrome components
Time Frame
3 months post-intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: High normal BP (office systolic BP: 130-139 mmHg and/or office diastolic BP: 85-89 mmHg) or grade 1 hypertension (office systolic BP: 140-159 mmHg and/or office diastolic BP: 90-99 mmHg) and low-moderate 10-year cardiovascular disease risk. Willingness to participate in a dietary intervention to control BP and to attend individual sessions. Signed informed consent form for participation. Exclusion Criteria: Current use of anti-hypertensive medications. Current use of any other medications or agents affecting BP levels (e.g., nonsteroidal anti-inflammatory drugs). Use of food supplements accompanied by a refusal to discontinue them. Participation in a clinical study involving a drug or device within 3 months of screening. Active weight loss or participation in a weight loss treatment program within 3 months of screening. Secondary hypertension. Atomic history of cardiovascular disease (e.g. acute myocardial infarction, stroke, heart failure). Diabetes Mellitus (Type 1 & 2). Chronic kidney disease, defined as an estimated Glomerular Filtration Rate (eGFR) <60 mL/min/1.73m2. Liver disease (e.g., hepatitis, cirrhosis). Lung disease (e.g., chronic obstructive pulmonary disease). Inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis). Celiac disease. Active malignancy or cancer therapy. Current major psychiatric disorder or current drug abuse. Body Mass Index >40 kg/m2. Current alcohol consumption >14 drinks per week. Current or planned pregnancy before the end of the study, or breast-feeding. Any concomitant conditions that in the opinion of the investigator interfere with the diet or other situations requiring specific nutritional management.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Konstantinos P Tsioufis, Prof.
Organizational Affiliation
First Cardiology Clinic, Hippocration General Hospital, NKUA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, National and Kapodistrian University of Athens
City
Athens
ZIP/Postal Code
11527
Country
Greece

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of the DASH vs. the Mediterranean Diet Combined With Salt Restriction on Blood Pressure Levels in Adults

We'll reach out to this number within 24 hrs